<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2024.85.20</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-383</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Нарушения гликокаликса при критических состояниях: патофизиологические и клинические аспекты</article-title><trans-title-group xml:lang="en"><trans-title>Glycocalyx disorders in critical conditions: pathophysiological and clinical aspects</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0082-1971</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьёва</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyeva</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ВОРОБЬЁВА Анна Павловна – врач анестезиолог-реаниматолог</p><p>г. Ставрополь</p></bio><bio xml:lang="en"><p>VOROBYEVA Anna Pavlovna – anesthesiologist-resuscitator of the intensive care and intensive care wards</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4705-3823</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быков</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bykov</surname><given-names>Y. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>БЫКОВ Юрий Витальевич – к.м.н., до- цент</p></bio><bio xml:lang="en"><p>BYKOV Yuri Vitalievich – PhD, assistant of professor of the Department of Department of Anesthesiology and Intensive care with a course of additional professorial education</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6892-3552</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батурин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Baturin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>БАТУРИН Владимир Александрович – д.м.н., проф., зав. кафедрой</p></bio><bio xml:lang="en"><p>BATURIN Vladimir Alexandrovich – MD, Professor, Head of the Department of Clinical Pharmacology, with the course of DPO</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4460-870X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муравьёва</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Muravyeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>МУРАВЬЁВА Алла Анатольевна – к.м.н., доцент</p></bio><bio xml:lang="en"><p>MURAVYEVA Alla AnatolyevnaPhD, assistant of professor of the Department of Department of Anesthesiology and Intensive care with a course of additional professorial education</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4009-1783</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Массоров</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Massorov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>МАССОРОВ Владислав Викторович – ординатор</p></bio><bio xml:lang="en"><p>MASSOROV Vladislav Viktorovich – resident of the department of Anesthesiology and Intensive care with a course of additional professorial education </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Городская детская клиническая больница им. Г.К. Филиппского<country>Россия</country></aff><aff xml:lang="en">G.K. Filippsky City Children's Clinical Hospital<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Ставропольский гос. медицин. ун-т МЗ РФ<country>Россия</country></aff><aff xml:lang="en">Stavropol State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>02</month><year>2025</year></pub-date><volume>0</volume><issue>1</issue><fpage>77</fpage><lpage>81</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воробьёва А.П., Быков Ю.В., Батурин В.А., Муравьёва А.А., Массоров В.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Воробьёва А.П., Быков Ю.В., Батурин В.А., Муравьёва А.А., Массоров В.В.</copyright-holder><copyright-holder xml:lang="en">Vorobyeva A.P., Bykov Y.V., Baturin V.A., Muravyeva A.A., Massorov V.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/383">https://ymj.elpub.ru/jour/article/view/383</self-uri><abstract><p>В предлагаемом обзоре рассмотрено участие гликокаликса (ГК) в патогенезе таких заболеваний, как сахарный диабет, сепсис, COVID-19, политравма, преэклампсия, эпилепсия и др. Описано уменьшение толщины ГК у пациентов с сахарным диабетом. Также отмечено влияние гипергликемии на структуру ГК. При сепсисе ГК повреждается свободными радикалами кислорода, которые высвобождаются циркулирующими лейкоцитами, что в свою очередь запускает каскад реакций, которые приводят к системному отеку, гиповолемии с дальнейшим развитием повреждения органов и тканей. При тяжёлой травме отмечается повреждение ГК, что сопровождается выделением синдекана, гепарансульфата, гиалуроновой кислоты в кровоток. Преэклампсия также сопряжена с повреждением ГК, что можно выявить по повышению специфических маркеров. Эпилепсия и многие другие неврологические заболевания связаны с нарушением гематоэнцефалического барьера, нарушение функции которого связано с дисфункцией ГК.</p></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim: to evaluate the results of clinical studies devoted to the study of the role of endothelial glycocalyx (GC) in the pathogenesis of critical conditions.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. Scientific information was searched in domestic (E-Library) and foreign databases (PubMed, Scopus, Oxford University Press, Springer, Web of Science Core Collection). 120 publications were analysed, 42 of them were selected to meet the requirements of the review.</p></sec><sec><title>Results</title><p>Results. GC is a gel-like polysaccharide-protein layer covering the surface of vascular endothelial cells. GC maintains homeostasis of the vascular network, including controlling vascular permeability and microvascular tone, preventing microvascular thrombosis, and regulating leukocyte adhesion. Endothelial GC damage is a universal link of pathogenesis in various pathological processes. The proposed review considers the structure and functions of GC, its participation in the pathogenesis of such diseases as diabetes mellitus, sepsis, covid-19, poly- trauma, pre-eclampsia, epilepsy and others. A decrease in GC thickness in patients with diabe- tes mellitus has been described. The effect of hyperglycaemia on GC structure has also been noted. In sepsis, GC is damaged by free oxygen radicals, which are released by circulating leukocytes, which in turn triggers a cascade of reactions that lead to systemic oedema, hypovo- laemia with further development of organ and tissue damage. In severe trauma, damage to GC is noted, which is accompanied by the release of syndecan, heparan sulfate, hyaluronic acid into the bloodstream. Preeclampsia is also associated with GC damage, which can be detected by elevation of specific markers. Epilepsy and many other neurological diseases are associated with disruption of the blood-brain barrier, whose dysfunction is associated with GC dysfunction.</p></sec><sec><title>Conclusion</title><p>Conclusion. Timely diagnosis of GC degradation can improve life prognosis and therapeutic outcomes in critically ill patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гликокаликс</kwd><kwd>сепсис</kwd><kwd>преэклампсия</kwd><kwd>политравма</kwd><kwd>эпилептический статус</kwd><kwd>коронавирусная инфекция</kwd><kwd>синдекан</kwd><kwd>гиалуроновая кислота</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glycocalyx</kwd><kwd>sepsis</kwd><kwd>pre-eclampsia</kwd><kwd>polytrauma</kwd><kwd>status epilepticus</kwd><kwd>coronavirus  infection</kwd><kwd>syndecan</kwd><kwd>hyaluronic acid</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева А.П., Быков Ю.В., Батурин В.А. Методы определения деструкции гликокаликса // Вестник молодого ученого. 2023. № 12. С. 36-40.</mixed-citation><mixed-citation xml:lang="en">Vorobyeva A.P., Bykov Yu.V., Baturin V.A. Metody opredeleniya destrukcii glikokaliksa [Methods of determing the destruction of glycocalyx]. Vestnik molodogo uchenogo [Journal of young scientists. 2023; 12:36-40 (In Russ.).]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vorobyeva A.P., Bykov Yu.V., Baturin V.A. Methods of determining the destruction of Glycocalyx// Journal of young scientists. 2023. 12. P.36-40.</mixed-citation><mixed-citation xml:lang="en">Vorobyeva A.P., Bykov YU.V., Baturin V.A. Rol' endotelial'nogo glikokaliksa v patogeneze zabolevanij [The role of endotelial glycocalyx in the pathogenesis of deseases]. Vestnik molodogo uchenogo [Journal of young scientists. 2023: 12:27-32 (In Russ.).]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева А.П., Быков Ю.В., Батурин В.А. Роль эндотелиального гликокаликса в патогенезе заболеваний // Там же. С. 27-32.</mixed-citation><mixed-citation xml:lang="en">Gonchar I.V., Balashov S.A.,. Valiev I.A., Melkumyanz A.M. Rol' endotelial'nogo glikokaliksa v mekhanogennoj regulyacii tonusa arterial'nyh sosudov [The role of endothelial glycocalyx in the mechanogenic regulation of arterial vascular tone]. Trudy moskovskogo fiziko-himicheskogo instituta [Proceedings of the Moscow Institute of Physics and Chemistry. 2017; 1: 101–108. (In Russ.).]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Vorobyeva A.P., Bykov Yu.V., Baturin V.A. The role of endotelial glycocalyx in the pathogenesis of deseases // Ibid. P. 27-32.</mixed-citation><mixed-citation xml:lang="en">Ilyina Ya.Yu., Fot E.V., Kuzkov V.V., Kirov M.Yu. Sepsis-inducirovannoe povrezhdenie endotelial'nogo glikokaliksa (obzor literatury) [Sepsis-induced damage of endothelial glycocalyx (literature review)]. Vestnik intensivnoj terapii imeni A.I. Sultanova [A.I. Sultanov Bulletin of intensive care. 2019; 2 (In Russ.).] DOI: 10.21320/1818474X-2019-2-32-39</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Гончар И.В., Балашов С.А., Валиев И.А., Мелькумянц А.М. Роль эндотелиального гликокаликса в механогенной регуляции тонуса артериальных сосудов // Труды московского физико-химич. ин-та. 2017. № 1. С. 101–108.</mixed-citation><mixed-citation xml:lang="en">Amengual-Gual M., Ulate-Campos A., Loddenkemper T.. Status epilepticus prevention, ambulatory monitoring, early seizure detection and prediction in at-risk patients // Seizure. 2019. 68. p.31-37. doi: 10.1016/j.seizure.2018.09.013. Epub 2018 Sep 18. PMID: 30391107.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gonchar I.V., Balashov S.A., Valiev I.A., Melkumyanz А.М. The role of endothelial glycocalyx in the mechanogenic regulation of arterial vascular tone // Proceedings of the Moscow Institute of Physics and Chemistry. 2017; 1: 101-108. 3; 12(1):27-32.</mixed-citation><mixed-citation xml:lang="en">Anand D., Ray S., Srivastava L., Bhargava S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients // Clin Biochem. 2016. 49. p. 76–76. doi:10.1016/j.clinbiochem.2016.02.014</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ильина Я.Ю., Фот Е.В., Кузьков В.В., Киров М.Ю. Сепсис-индуцированное повреждение эндотелиального гликокаликса (обзор литературы) // Вестник интенсивн. терапии им. А.И. Солтанова. 2019. №2.DOI: 10.21320/1818474X-2019-2-32-39</mixed-citation><mixed-citation xml:lang="en">Bihari S., Wiersema U., Perry R. Schembri D., Bouchier T., Dixon D., et al. Efficacy and safety of 20% albumin fluid loading in healthy subjects: a comparison of four resuscitation fluids // J kAppl Physiol. 2019. 126. p. 46–60. doi: 10.1152/japplphysiol.01058.2018</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ilyina Ya.Yu., Fot E.V., Kuzkov V.V., Kirov M.Yu. Sepsis-induced damage of endothelial glycocalyx (literature review) // Bulletin of intensive care named after A.I. Sultanov. 2019. №2.DOI: 10.21320/18-474 X-2019-2-32-39</mixed-citation><mixed-citation xml:lang="en">Carlberg N., Cluver C., Hesse C., Thörn S., Gandley R., Damén T., Bergman L. Circulating concentrations of glycocalyx degradation products in preeclampsia // Front. Physiol. 2022 Sec.Clinicaland Translational Physiology. Vol.13. DOI:10.3389/fphys.2022.1022770</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Amengual-Gual M., Ulate-Campos A., Loddenkemper T.. Status epilepticus prevention, ambulatory monitoring, early seizure detection and prediction in at-risk patients // Seizure. 2019. 68. p.31-37. doi: 10.1016/j.seizure.2018.09.013. Epub 2018 Sep 18. PMID: 30391107.</mixed-citation><mixed-citation xml:lang="en">Chappell L., Cluver C., Kingdom J., Tong S. Pre-eclampsia. Lancet. Vol.398. p.341–354. doi:10.1016/S0140-6736(20)32335-7</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Anand D., Ray S., Srivastava L., Bhargava S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients // Clin Biochem.2016. 49. P. 76–76. doi: 10.1016/j.clinbiochem.2016.02.014</mixed-citation><mixed-citation xml:lang="en">Chen W., Ju X., Lu Y., et al. Propofol improved hypoxia-impaired integrity of blood-brain barrier via modulating the expression and phosphorylation of zonula occludens-1. CNS Neurosci Ther. 2019; 25: 704-713</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bihari S., Wiersema U., Perry R. Schembri D., Bouchier T., Dixon D., et al. Efficacy and safety of 20% albumin fluid loading in healthy subjects: a comparison of four resuscitation fluids // J Appl Physiol. 2019. 126. P. 46–60. doi: 10.1152/ japplphysiol.01058.2018</mixed-citation><mixed-citation xml:lang="en">Drost C., Rovas A., Kümpers P. Protection and rebuilding of the endothelial glycocalyx in sepsis–Science or fiction? Matrix Biol. Plus. 2021;12:100091</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Carlberg N., Cluver C., Hesse C., Thörn S., Gandley R., Damén T., Bergman L. Circulating concentrations of glycocalyx degradation products in preeclampsia // Front. Physiol. 2022 Sec.Clinicaland Translational Physiology. Vol.13. DOI:10.3389/fphys.2022.1022770</mixed-citation><mixed-citation xml:lang="en">Fraser D., Patterson E., Daley M., Cepinskas G. Case report: inflammation and endothelial injury profiling of COVID-19 pediatric multisystem inflammatory syndrome (MIS-C). Front Pediatr. 2021. DOI: 10.3389/ fped.2021.597926</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell L., Cluver C., Kingdom J., Tong S. Pre-eclampsia // Lancet. Vol.398. P.341–354. doi:10.1016/S0140-6736(20)32335-7</mixed-citation><mixed-citation xml:lang="en">Fraser D., Patterson E., Slessarev M., Gill S., Martin C., Daley M. et al. Endothelial injury and glycocalyx degradation in critically Ill Coronavirus disease 2019 patients: implications for microvascular platelet aggregation. Crit Care Explorat. 2020. DOI: 10.1097/CCE.0000000000000194.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chen W., Ju X., Lu Y., et al. Propofol improved hypoxia-impaired integrity of blood-brain barrier via modulating the expression and phosphorylation of zonula occludens-1 // CNS Neurosci Ther. 2019. Vol. 25. P. 704-713</mixed-citation><mixed-citation xml:lang="en">Frati-Munari A. Medical significance of endothelial glycocalyx. Arch Cardiol Mex. 2013; 83:03–312. DOI: 10.1016/j.acmx.2013.04.015</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Drost C., Rovas A., Kümpers P. Protection and rebuilding of the endothelial glycocalyx in sepsis–Science or fiction? // Matrix Biol. Plus. 2021. Vol.12. 100091</mixed-citation><mixed-citation xml:lang="en">Gestational hypertension and preeclampsia: ACOG Practice Bulletin, number 222. Obstet. Gynecol. 2020; 135(6):e237-e60.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fraser D., Patterson E., Daley M., Cepinskas G. Case report: inflammation and endothelial injury profiling of COVID-19 pediatric multisystem inflammatory syndrome (MIS-C) // Front Pediatr. 2021. Vol. DOI: 10.3389/ fped.2021.597926</mixed-citation><mixed-citation xml:lang="en">Global Health Estimates 2020: Deaths By Cause, Age, Sex, By Country And By Region, 2000-2019. Geneva, World Health Organization. 2020.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fraser D., Patterson E., Slessarev M., Gill S., Martin C., Daley M. et al. Endothelial injury and glycocalyx degradation in critically Ill Coronavirus disease 2019 patients: implications for microvascular platelet aggregation // Crit Care Explorat. 2020. DOI: 10.1097/CCE.0000000000000194</mixed-citation><mixed-citation xml:lang="en">Glykys J., Dzhala V., Egawa K., Kahle K., Delpire E., Staley K. Chloride Dysregulation, Seizures and Cerebral Edema: A Relationship with Therapeutic Potential. Trends Neurosci. 2017; 40: 276-294. doi: 10.1016/j.tins.2017.03.006</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Frati-Munari A. Medical significance of endothelial glycocalyx. Arch Cardiol Mex. 2013. Vol. 83. p. 03–312. DOI: 10.1016/j.acmx.2013.04.015</mixed-citation><mixed-citation xml:lang="en">Han H., Mann A., Ekstein D., Eyal S. Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy. AAPS J. 2017; 19: 973-988. doi: 10.1208/s12248-017-0096-2</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Global Health Estimates 2020: Deaths By Cause, Age, Sex, By Country And By Region, 2000-2019. Geneva, World Health Organization. 2020.</mixed-citation><mixed-citation xml:lang="en">Haymet A., Bartnikowski N., Wood E., Vallely M., McBride A., Yacoub S., Biering S., Harris E., Suen, J., Fraser J. Studying the Endothelial Glycocalyx in vitro: What Is Missing? Front. Cardiovasc. Med. 2021; 8: 280.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Glykys J., Dzhala V., Egawa K., Kahle K., Delpire E., Staley K. Chloride Dysregulation, Seizures and Cerebral Edema: A Relationship with Therapeutic Potential // Trends Neurosci. 2017. Vol. 40. P. 276-294. doi: 10.1016/j. tins.2017.03.006</mixed-citation><mixed-citation xml:lang="en">Hippensteel J., Uchimido R., Tyler P., Burke R., Han X., Zhang F. et al. Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Crit. Care 23. 1, 259. doi:10.1186/s13054-019-2534-2</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gusev EY, Zotova NV. Cellular stress and general pathological processes. Curr Pharm Des. 2019; 25(3): 251-297. DOI: 10.2174/1381612825 666190319114641.</mixed-citation><mixed-citation xml:lang="en">Holcomb J., Tilley B., Baraniuk S., Fox E., Wade C., Podbielski J., [et al.].Transfusion Of Plasma, Platelets, And Red Blood Cells In A 1:1:1 vs A 1:1:2 Ratio And Mortality In Patients With Severe Trauma: The PROPPR Randomized Clinical Trial. JAMA. 2015; 313: 471-482</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Han H., Mann A., Ekstein D., Eyal S. Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy. AAPS J. 2017. Vol. 19. P. 973-988. doi: 10.1208/s12248-017-0096-2</mixed-citation><mixed-citation xml:lang="en">Kalagara T., Moutsis T., Yang Y., Pappelbaum K., Farken A., Cladder-Micus L., Vidal-Y-Sy S., John A., Bauer A.T., Moerschbacher B.M., [et al.] The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. Blood Adv. 2018; 2: 2347–2357</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hippensteel J., Uchimido R., Tyler P., Burke R., Han X., Zhang F. et al. Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation // Crit. Care. 23. 1, 259. doi:10.1186/s13054-019-2534-2</mixed-citation><mixed-citation xml:lang="en">Karamysheva A. Mechanisms of angiogenesis. Biochemistry. 2008; 73:751–762.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Holcomb J., Tilley B.,Baraniuk S., Fox E., Wade C., Podbielski J. Transfusion Of Plasma, Platelets, And Red Blood Cells In A 1:1:1 vs A 1:1:2 Ratio And Mortality In Patients With Severe Trauma: The PROPPR Randomized Clinical Trial. JAMA, 313 (2015). P. 471-482</mixed-citation><mixed-citation xml:lang="en">Kuessel L., Husslein H., Montanari E., Kundi M., Himmler G., Binder J., [et al.]. Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: A nested case control study. Clin. Chem. Lab. Med. 58: 50–58. doi:10.1515/cclm2019-0686</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Johansson PI, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, et al. Traumatic endotheliopathy: a prospective observational study of 424 severely injured patients. Ann Surg. 2017; 265(3): 597-603. DOI: 10.1097/ SLA.0000000000001751.</mixed-citation><mixed-citation xml:lang="en">Li X., Zhu J., Liu K., Hu Y., Huang K., Pan S. Heparin ameliorates cerebral edema and improves outcomes following status epilepticus by protecting endothelial glycocalyx in mice. Experimental Neurology. 2020; 330.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Karamysheva A. Mechanisms of angiogenesis // Biochemistry. 2008. Vol. 73. P.751-762.</mixed-citation><mixed-citation xml:lang="en">Moore E., Moore H., Kornblith L., Neal M., Hoffman M., Mutch N., et al. Trauma-induced coagulopathy. Nat Rev Dis Primers. 2021;7:1–23. doi: 10.1038/s41572-021-00264-3</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kuessel L., Husslein H., Montanari E., Kundi M., Himmler G., Binder J., et al. Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: A nested case control study // Clin. Chem. Lab. Med. Vol. 58. P.50–58. doi:10.1515/cclm2019-0686</mixed-citation><mixed-citation xml:lang="en">Naumann D., Hazeldine J., Davies D., Bishop J., Midwinter M., Belli A., Endotheliopathy Of Trauma Is An On-Scene Phenomenon, And Is Associated With Multiple Organ Dysfunction Syndrome: A Prospective Observational. StudyShock. 2018; 49: 420-428</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Zhu J., Liu K., Hu Y., Huang K., Pan S. Heparin ameliorates cerebral edema and improves outcomes following status epilepticus by protecting endothelial glycocalyx in mice. Experimental Neurology. Vol. 330. 2020.</mixed-citation><mixed-citation xml:lang="en">Naumann D., Hazeldine J., Midwinter M., Hutchings S., Harrison P. Poor microcirculatory flow dynamics are associated with endothelial cell damage and glycocalyx shedding after traumatic hemorrhagic shock. J Trauma Acute Care Surg. 2018; 84:8. DOI: 10.1097/ TA.0000000000001695</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">McDonald SJ, Sun M, Agoston DV, Shultz SR. The effect of concomitant peripheral injury on traumatic brain injury pathobiology and outcome. J Neuroinflammation. 2016; 13(1): 90. DOI: 10.1186/ s12974-016-0555-1.</mixed-citation><mixed-citation xml:lang="en">Nelson A., Berkestedt I., Bodelsson M. Circulating glycosaminoglycan species in septic shock. Acta Anaesth Scand. 2014; 58: 36–43. DOI: 10.1111/aas.12223</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Moore E., Moore H., Kornblith L., Neal M., Hoffman M., Mutch N., et al. Trauma-induced coagulopathy // Nat Rev Dis Primers. 2021. Vol. 7. P.1-23. doi: 10.1038/s41572-021-00264-3</mixed-citation><mixed-citation xml:lang="en">Ostrowski S., Windeløv N. Ibsen M., Haase N., Perner A, Johansson P. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. J Crit Care. 2013; 28:1–11. doi: 10.1016/j.jcrc.2012.09.003</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Naumann D., Hazeldine J., Davies D., Bishop J., Midwinter M., Belli A., Endotheliopathy Of Trauma Is An On-Scene Phenomenon, And</mixed-citation><mixed-citation xml:lang="en">Patterson E., Cepinskas G., Fraser D. Endothelial Glycocalyx Degradation in Critical Illness and Injury. Sec. Intensive Care Medicine and Anesthesiology. 2022 9. DOI: 10.3389/ fmed.2022.898592</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Is Associated With Multiple Organ Dysfunction Syndrome: A Prospective Observational // StudyShock. 49. 2018. P. 420-428</mixed-citation><mixed-citation xml:lang="en">Perucci L., Corrêa M., Dusse L., Gomes K., Sousa L. Resolution of inflammation pathways in preeclampsia-a narrative review. Immunol. Res. 2017:65:774–789.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Naumann D., Hazeldine J., Midwinter M., Hutchings S., Harrison P. Poor microcirculatory flow dynamics are associated with endothelial cell damage and glycocalyx shedding after traumatic hemorrhagic shock // J Trauma Acute Care Surg. 2018. Vol. 84. P. 8. DOI: 10.1097/ TA.0000000000001695</mixed-citation><mixed-citation xml:lang="en">Piotti A., Novelli D., Meessen JMTA, Ferlicca D., Coppolecchia S., Marino A., [et al.]. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Crit Care. 2021. 25:113. DOI 10.1186/s13054-021-03545-1</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson A., Berkestedt I., Bodelsson M. Circulating glycosaminoglycan species in septic shock // Acta Anaesth Scand. 2014. Vol. 58. p. 36–43. DOI: 10.1111/aas.12223</mixed-citation><mixed-citation xml:lang="en">Polites S., Moody S., Williams R., Kayton M., Alberto E., Burd R., [et al.]. Timing And Volume Of Crystalloid And Blood Products In Pediatric Trauma: An Eastern Association For The Surgery Of Trauma Multicenter Prospective Observational Study. Trauma Acute Care Surg. 2020; 82:36-42</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ostrowski S., Windeløv N. Ibsen M., Haase N., Perner A, Johansson P. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study // J Crit Care. 2013. Vol. 28. P.1-11. doi: 10.1016/j. jcrc.2012.09.003</mixed-citation><mixed-citation xml:lang="en">Queisser K., Mellema R., Middleton E., Portier I., Manne B., Denorme F. [et al.]. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight. 2021; 6:e147472. DOI: 10.1172/jci. insight.147472</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Patterson E., Cepinskas G., Fraser D. Endothelial Glycocalyx Degradation in Critical Illness and Injury // Sec. Intensive Care Medicine and Anesthesiology. 2022 9. DOI: 10.3389/ fmed.2022.898592</mixed-citation><mixed-citation xml:lang="en">Rapkiewicz A., Mai X., Carsons S., Pittaluga S., Kleiner D., Berger J. et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine. 2020; 24:100434. DOI: 10.1016/j.eclinm.2020.100434</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Perucci L., Corrêa M., Dusse L., Gomes K., Sousa L. Resolution of inflammation pathways in preeclampsia-a narrative review //Immunol. Res. 2017. Vol. 65. P.774–789.</mixed-citation><mixed-citation xml:lang="en">Rovas A., Osiaevi I., Buscher K., Sackarnd J., Tepasse P-R, Fobker M, et al. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis. 2021; 24:145–57. DOI: 10.1007/ s10456-020-09753-7</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Piotti A., Novelli D., Meessen JMTA, Ferlicca D., Coppolecchia S., Marino A., et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS // Crit Care. 2021. 25:113. DOI 10.1186/s13054-021-03545-1</mixed-citation><mixed-citation xml:lang="en">Singer M., Deutschman C., Seymour C., Shankar-Hari M., Annane D., Bauer M., [et al.]. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 315:801–10. DOI: 10.1001/ jama.2016.0287</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Polites S., Moody S., Williams R., Kayton M., Alberto E., Burd R. Timing And Volume Of Crystalloid And Blood Products In Pediatric Trauma: An Eastern Association For The Surgery Of Trauma Multicenter Prospective Observational Study // Trauma Acute Care Surg. 2020. Vol. 82. P. 36-42</mixed-citation><mixed-citation xml:lang="en">Tomimatsu T., Mimura K., Matsuzaki S., Endo M., Kumasawa K., Kimura T. (2019). Preeclampsia: Maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int. J. Mol. Sci. 2022; (17): E4246. doi:10.3390/ ijms20174246</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Rapkiewicz A., Mai X., Carsons S., Pittaluga S., Kleiner D., Berger J. et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series // EclinicalMedicine. 2020. 24:100434. DOI: 10.1016/j.eclinm.2020.100434</mixed-citation><mixed-citation xml:lang="en">Uchimido R., Schmidt E.P., Shapiro N.I. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit. Care. 2019; 23:16. DOI: 10.1186/s13054-018-2292-6</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Rovas A., Osiaevi I., Buscher K., Sackarnd J., Tepasse P-R, Fobker M, et al. Microvascular dysfunction in COVID-19: the MYSTIC study // Angiogenesis. 2021. 24:145-57. DOI: 10.1007/ s10456-020-09753-7</mixed-citation><mixed-citation xml:lang="en">Weissgerber T., Garcia-Valencia O., Milic N., Codsi E., Cubro H., Nath M. C., et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion. J. Am. Heart Assoc. 2019; 8: e010647. doi:10.1161/JAHA.118.010647</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Singer M., Deutschman C., Seymour C., Shankar-Hari M., Annane D., Bauer M. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA.2016 315:801-10. DOI: 10.1001/jama.2016.0287</mixed-citation><mixed-citation xml:lang="en">Yang T., Guo R., Zhang F. Brain perivascular macrophages: Recent advances and implications in health and diseases. CNS Neurosci Ther. 2019; 25:318-1328.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Tomimatsu T., Mimura K., Matsuzaki S., Endo M., Kumasawa K., Kimura T. (2019). Preeclampsia: Maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int. J. Mol. Sci. 2022 (17), E4246. doi:10.3390/ ijms20174246</mixed-citation><mixed-citation xml:lang="en">Zhang D., Li L., Chen Y., Ma J., Yang Y., Aodeng S., et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol Med. 2021. 27:151. doi: 10.1186/ s10020-021-00412-1</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Uchimido R., Schmidt E.P., Shapiro N.I. The glycocalyx: a novel diagnostic and therapeutic target in sepsis // Crit. Care. 2019. Vol. 23. P.16. DOI: 10.1186/s13054-018-2292-6</mixed-citation><mixed-citation xml:lang="en">Uchimido R., Schmidt E.P., Shapiro N.I. The glycocalyx: a novel diagnostic and therapeutic target in sepsis // Crit. Care. 2019. Vol. 23. P.16. DOI: 10.1186/s13054-018-2292-6</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Weissgerber T., Garcia-Valencia O., Milic N., Codsi E., Cubro H., Nath M. C., et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion // J. Am. Heart Assoc. 2019. Vol. 8. e010647. doi:10.1161/JAHA.118.010647</mixed-citation><mixed-citation xml:lang="en">Weissgerber T., Garcia-Valencia O., Milic N., Codsi E., Cubro H., Nath M. C., et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion // J. Am. Heart Assoc. 2019. Vol. 8. e010647. doi:10.1161/JAHA.118.010647</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Yang T., Guo R., Zhang F. Brain perivascular macrophages: Recent advances and implications in health and diseases // CNS Neurosci Ther. 2019. Vol. 25. P. 318-1328.</mixed-citation><mixed-citation xml:lang="en">Yang T., Guo R., Zhang F. Brain perivascular macrophages: Recent advances and implications in health and diseases // CNS Neurosci Ther. 2019. Vol. 25. P. 318-1328.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang D., Li L., Chen Y., Ma J., Yang Y., Aodeng S., et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 // Mol Med. 2021. 27:151. doi: 10.1186/s10020-021-00412-1</mixed-citation><mixed-citation xml:lang="en">Zhang D., Li L., Chen Y., Ma J., Yang Y., Aodeng S., et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 // Mol Med. 2021. 27:151. doi: 10.1186/s10020-021-00412-1</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Zotova NV, Zhuravleva YV, Zubova TE, Gusev EYu. Integral estimation of systemic inflammatory response under sepsis. Gen Physiol Biophys. 2020; 39(1): 13-26. DOI: 10.4149/ gpb_2019043.</mixed-citation><mixed-citation xml:lang="en">Zotova NV, Zhuravleva YV, Zubova TE, Gusev EYu. Integral estimation of systemic inflammatory response under sepsis. Gen Physiol Biophys. 2020; 39(1): 13-26. DOI: 10.4149/ gpb_2019043.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
